Pharmafile Logo
Pharmafocus logo
Advanced Search

Indian Pharma

Showing 5 posts of 5 posts found.

medications-money-cure-tablets

Indian regulators approve first drug for patients with NASH

March 6, 2020
Medical Communications FDA Approval, India, Indian Pharma, drug approval

The Drug Controller General of India (DCGI) has approved the marketing application for Zydus Cadila’s saroglitazar to treat patients with …

News
5204602349_c87b204860_b_1

FDA teams up with Indian government to crack down on illicit drugs shipments

February 19, 2020
Research and Development FDA, FDA India, FDA trade, Indian Pharma

The FDA announced yesterday its first successful bilateral enforcement operation with the Government of India, where they stopped 500 shipments …

News
money-1811937_960_720

India considering export restrictions on antibiotics due to coronavirus

February 17, 2020
Sales and Marketing Chinese Coronavirus, Indian Pharma, Wuhan, china coronavirus, coronavirus, drugs

The Indian government is considering an export ban on antibiotics, vitamins and hormones due to the lockdown of Hubei province, …

News
dw-anzcxqaqavhl

FDA warning letters to Indian pharmaceutical companies double in 2019

January 20, 2020
Sales and Marketing Indian Pharma, Indian Pharmaceuticals

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019 compared …

News
indian_pharma

Study shows widespread bribery in Indian pharmaceutical industry

November 29, 2019
Medical Communications India, Indian Pharma, Modi, bribery

A recent report by the Support for Advocacy and Training to Health Initiatives (Sathi) revealed the widespread use of bribes …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024